Crescent Capital BDC, Inc. (CCAP) AI Stock Analysis

Crescent Capital BDC, Inc. is a business development company within the financial sector that specializes in providing debt and equity financing to middle-market companies. The firm focuses on investing in private businesses that demonstrate potential for expansion and profitability, frequently collaborating with management teams to assist with strategic initiatives and financial restructuring. Crescent Capital concentrates on traditional debt and equity instruments, prioritizing risk management, stability, and prudent stewardship rather than participating in areas like cryptocurrency.

Crescent Capital achieved a 5-year revenue CAGR of 27.4% from FY2020 to FY2025. Annual revenue expanded from $81.3M in FY2021 to $156.2M in FY2025, though net income fell from $83.6M to $34.5M over the same period, with net margin declining to 22.1%. In FY2025, operating margin reached 76.1% with diluted EPS of $1.77. Over the trailing twelve months, revenue stood at $156.4M, with an operating margin of 78.4% and a net profit margin of -2.0%. For the latest quarter ended June 30, 2026, quarterly revenue fell 15.5% year-over-year, while quarterly earnings dropped 14.9%.

As of June 30, 2026, Crescent Capital held $15.6M in cash and short-term investments against total debt of $922.9M, leaving net debt at $907.3M. Total assets were $1.62B against shareholders' equity of $656.5M, reflecting a debt-to-equity ratio of 1.41 and a current ratio of 1.17. In FY2025, operating cash flow and free cash flow both reached $74.7M. Crescent Capital directed capital toward distributions and share repurchases, paying $67.8M in dividends and deploying $1.3M for share buybacks during FY2025.

At $8.90, Crescent Capital has a market cap of $327.9M and an enterprise value of $1.24B. The stock trades at a forward P/E of 7.0x and a price-to-sales ratio of 2.1x, below the median of its US-listed Financial Services peers of 10.8x and 3.2x, respectively. It has a price-to-book ratio of 0.5x and a PEG of 0.89. Over the past year, Crescent Capital declined 23.9%, trailing the S&P 500 (SPY) return of 16.8%. Over five years, the stock returned -22.8% versus 83.0% for the S&P 500.

Crescent Capital pays a forward annual dividend of $1.52 per share, which equates to a dividend yield of 17.06%. The payout ratio is 43.8%, and the company has maintained 7 consecutive years of payments. The annualized 5-year dividend growth rate is 2.2%, with the last ex-dividend date on November 30, 2026.

Wall Street coverage includes 1 Strong Buy, 1 Buy, and 5 Hold recommendations, with no Sell or Strong Sell ratings. The mean price target of $12.25 sits 37.6% above the last close of $8.90. For the fiscal year ending December 31, 2026, analysts estimate revenue of $147.0M and EPS of $1.48, which indicates an 18.1% decline in EPS. Crescent Capital has beaten EPS expectations in 2 of the last 4 quarters, and the next earnings date is November 11, 2026.

This page is an AI-written research summary of Crescent Capital BDC, Inc. (CCAP). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: CCAP income statement, CCAP balance sheet, CCAP key metrics, CCAP analyst forecast, CCAP chart. See the CCAP stock overview for the latest quote and news.